FindTrial
Sign In

Clinico-pathological study on the effectiveness of cepharanthin on the prevention of destruction of acinar structure in Sjogren's syndrome patients

Clinico-pathological study on the effectiveness of cepharanthin on the prevention of destruction of acinar structure in Sjogren's syndrome patients - Effectiveness of cepharanthin on the acinar structure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005878
Enrollment
10
Registered
2011-07-31
Start date
2011-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren&#39

Interventions

cepharanthin

Sponsors

Department of Oral Medicine, Institute of Health Biosciences, The University of Tokushima Graduate Faculty of Dentistry
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Primary Sjogren's syndrome

Exclusion criteria

Exclusion criteria: Secondary Sjogren's syndrome, Xerostomia due to aging

Design outcomes

Primary

MeasureTime frame
Improvement of infiltration of lymphocytes, Improvement of destruction of acinar structure—

Secondary

MeasureTime frame
Increase in salivary flow, Improvement of CRP level—

Countries

Japan

Contacts

Public ContactKeiko Aota

Tokushima University Hoapital Department of Oral Medicine

088-633-7352

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026